[Branch retinal vein occlusion following infliximab treatment: case report]

Arq Bras Oftalmol. May-Jun 2011;74(3):214-6. doi: 10.1590/s0004-27492011000300015.
[Article in Portuguese]

Abstract

A case of a 53 year-old female patient who developed branch retinal vein occlusion after six 3 mg/kg Infliximab infusions for rheumatoid arthritis treatment is reported. Hematological disorders, cardiopathy and chronic systemic hypertension evaluation were negative. The relationship between the infliximab therapy and the development of retinal vein occlusion raises awareness of the possibility of a potential side effect of this medication.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Female
  • Fluorescein Angiography
  • Humans
  • Infliximab
  • Middle Aged
  • Retinal Vein Occlusion / chemically induced*
  • Visual Acuity

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab